Coronary endarterectomy (CE) may provide a useful adjunct to coronary artery bypass grafting (CABG) in patients with extensive, diffuse coronary atheroma. However, concerns regarding its morbidity and mortality have created uncertainty as to the role of CE in the current era. The aim of this study was therefore to quantitatively summarize the short-and long-term outcomes of CE. Twenty observational studies were identified by systematic literature search, incorporating 54 440 patients (7366 CABG + CE; 47 074 CABG only), which were analysed using random-effects modelling. Heterogeneity, subgroup analysis, quality scoring and risk of bias were assessed. Primary end-points were 30-day mortality and perioperative and postoperative myocardial infarction (MI). Secondary end-points were postoperative morbidity, intensive care unit (ITU) stay, hospital stay and long-term graft patency. Adjunctive CE significantly increased 30-day mortality [odds ratios (OR) = 1.69, 95% confidence interval (CI) [1.49-1.92], P <0.00001], perioperative (OR = 2.10, 95% CI [1.82-2.43], P <0.00001) and postoperative MI (OR = 3.34, 95% CI [1.74-6.41], P = 0.0003) when compared with CABG alone. Furthermore, postoperative ventricular arrhythmias, pulmonary complications, renal failure and inotrope use were significantly greater in patients undergoing adjunct CE. CE also increased ITU and hospital stay and reduced angiographic patency at the last follow-up (OR = 0.57, 95% CI [0.36-0.88]). Increased 30-day morbidity and mortality continues to raise concerns over the safety of adjunct CE. Furthermore, the procedure can be associated with worse long-term graft patency. To better determine whether CE should remain a viable adjunct to CABG, novel studies must focus on collecting prospective data with homogeneous inclusion criteria for CE as well as isolating outcomes for different coronary vessels and standardizing postoperative anticoagulation.
INTRODUCTION
Over recent years, the profile of patients referred for coronary artery bypass grafting (CABG) has become increasingly complex. A growing proportion of patients are older, with diffuse disease and multiple comorbidities, and many have undergone previous percutaneous coronary intervention [1] . In the past, coronary endarterectomy (CE) had been popularized to achieve complete revascularization in the setting of complex, diffuse coronary disease, where an acceptable distal target could not be found. However, although early reports demonstrated symptomatic relief from angina, an increase in perioperative myocardial infarction (MI) [2] , postoperative morbidity and early mortality [3] [4] [5] [6] led to major concerns over the safety of this procedure [7] . Despite this, the changing pattern and increasing complexity of coronary disease have led to CE being reconsidered as a treatment strategy in selected cases and, thus, reassessment of the technique, its indications and outcomes is now necessary [7] .
CE can be performed using either an open or a closed approach [8] . Open endarterectomy involves incising the coronary artery throughout the length of the stenosis, proximally transecting the atheroma and carefully dissecting out the plaque, including any extensions into coronary side branches. The vessel is then closed using an autologous patch of either saphenous vein or mammary artery. Bypass grafting may be performed onto the patch where necessary [9] . Closed endarterectomy is performed through a small arteriotomy made over a proximal area of the plaque. Subsequently, careful dissection between the lamina of the vascular wall and the atheroma is followed by gentle traction on the plaque to enable the cast of atheroma to be removed. Care must be taken to minimize vascular trauma and the risk of proximal dissection. One or more small bridging arteriotomies may be required distally to facilitate plaque removal, particularly from side branches [10] .
Comparative studies evaluating CE versus CABG have been criticized for their non-randomized nature and inherent selection bias [11] . As such, endarterectomy patients tend to have more complex, diffuse disease patterns compared with those undergoing CABG. Furthermore, outcomes for right and left CE may be distinctly different, with endarterectomy to the left anterior descending (LAD) artery being associated with increased morbidity and mortality compared with other vessels.
Despite several studies into role of adjunctive CE, there is continued uncertainty regarding its potential. The purpose of this study is therefore to provide a quantitative summary of the available evidence surrounding the use of CE in combination with CABG to inform current practice. Our primary aim was to evaluate the effect of CE on the incidence of peri-and postoperative MI and early mortality. Secondarily, we considered its impact on major morbidities, length of stay and overall vessel patency at follow-up.
MATERIALS AND METHODS

Literature search
A systematic literature search was performed of the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Ovid Medline and EMBASE electronic databases using the following search terms: 'coronary vessels', 'heart' and 'endarterectomy'. The last date for this search was 23 November 2013. The primary search was supplemented with searches of: (i) PubMed-related articles; and (ii) clinicaltrials.gov. A summary of the search strategy is shown in Fig. 1 .
Inclusion and exclusion criteria
All articles reporting the use of CE in the treatment of coronary artery disease, which were comparative between CE with CABG and CABG only, were included. Studies with more than two arms, comparing other interventions, such as patch reconstruction, were included, but the data were only extracted from the relevant patient groups. No language restrictions were imposed. Where data were duplicated, the most recent study or that with the largest sample size was preferentially considered.
Based on these criteria, two reviewers (E.S. and L.H.) independently selected studies for further examination by title and abstract review of all identified citations. All potentially eligible studies were retrieved and examined in full. Any disagreement was resolved by discussion with the senior author (T.A.).
Data extraction
Two authors (E.S. and L.H.) independently extracted the following data using a standardized spreadsheet: first author, year of publication, study type, number of subjects, population demographics, technique of CE, coronary vessel endarterectomized, type of conduit, use of cardiopulmonary bypass (CPB) and of antiplatelets or anticoagulants. All laboratory, physiological and clinical outcome measures used by the included studies were recorded. Specific outcome data were retrieved where possible for the following: (i) primary end-points: 30-day (early) mortality, perioperative and postoperative (as classified by the authors) MI; and (ii) secondary end-points: ventricular arrhythmias, pulmonary complications, postoperative renal failure, inotrope use, blood transfusion, intensive care unit (ICU) stay, hospital stay and long-term graft patency. Meta-analysis was performed in line with recommendations of the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Metaanalyses (PRISMA) guidelines [12] . 
STATE-OF-THE-ART
Sensitivity analysis
To evaluate potential sources of heterogeneity, sensitivity analysis was performed for the following: (i) studies published after year 2000; (ii) study size (n ≥100); (iii) studies with quality score ≥8; and (iv) studies with matched CABG and CABG + CE groups.
Quality scoring and risk-of-bias assessment
A modified Newcastle-Ottawa scale (Supplementary Table 1 ) was used to assess the methodological quality of included studies. This star-based system considered the following points: (i) patient selection; (ii) intergroup comparability; and (iii) outcome assessment (maximum 3, 10 and 2 stars, respectively; total /15). The 10 singlestar variables used to grade comparability among study groups included age, gender, hypertension, ejection fraction, three-vessel disease, left mainstem disease, urgent/emergent operation, myocardial viability and surgeon/hospital volume. Quality scoring of included studies was independently assessed by two authors (E.S. and L.H.), with 100% inter-rater agreement.
A domain-based evaluation of risk of bias was performed in accordance with the guidelines outlined in the Cochrane Handbook for Systematic Reviews or Interventions version 5.1.7. Two authors (L.H. and E.S.) subjectively reviewed all studies included in this review and assigned a value of 'yes', 'no' or 'unclear' to the following questions: (i) was the allocation sequence adequately generated? (ii) Was allocation adequately concealed? (iii) Was there blinding of participants, personnel and outcome assessors? (iv) Were incomplete outcome data sufficiently assessed? And (v) Are reports in the study free of the suggestion of selective outcome reporting?
'Risk-of-bias' plots were performed using Review Manager® Version 5.1.7 for Windows (The Cochrane Collaboration, Software Update, Oxford, UK). Publication bias was assessed by visual inspection of funnel plots in addition to statistical estimation of small study effects using both Begg and Mazumdar's test and Egger's test for small study effects.
RESULTS
Eligible studies, variations in technical approach and quality assessment Twenty publications [2, 7, 11, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] were identified as those fulfilling our inclusion criteria, producing a pooled data set of 54 440 patients. Of these, 7366 (13.5%) underwent CABG with CE and 47 074 (86.5%) patients underwent CABG alone. Twelve studies were of retrospective cohort design [2, 7, 11, 15, 20, 22, 24-26, 28, 29] , two were prospective cohort [14, 21] , five were cohort studies without further specification [16] [17] [18] [19] 23] and one study was a retrospective analysis of prospectively collected data from a randomized control trial into on-versus off-pump coronary revascularization [13] . Full study characteristics are shown in Table 1 .
One study examined only endarterectomy of the LAD artery [24] and three examined only the right coronary artery [15, 16, 20] . The remaining 16 studies looked at both right and left coronary systems [2, 7, 11, 13, 14, 17-19, 21-23, 25-29] . Nine studies reported both 'open' and 'closed' endarterectomy techniques [2, 11, 14, 17, 18, [21] [22] [23] 26] , seven studies used only a 'closed' technique [7, 13, 15, 16, 19, 20, 28] and only Tasdemir et al. used the 'open' method [24] . Three studies did not specify endarterectomy technique used [25, 27, 29] . Notably, RCA endarterectomy was most commonly performed using the closed method [2, 7, 11, 13, 15, 16, 19, 20, 22, 23] , whereas LAD endarterectomy was most commonly performed using the open method [2, 11, [22] [23] [24] .
Nine studies reported using both saphenous vein and internal thoracic artery conduit [11, 13, 15, 17, 21, [23] [24] [25] 28] . Three used saphenous vein only [16, 18, 26] and the remaining eight did not specify the type of conduit used [2, 7, 14, 19, 20, 27, 29] . On-pump-only procedures were performed in 12 studies [2, 7, 11, 16, 19-22, 24-26, 28 ], 3 used both on-and off-pump method [13, 15, 23] , and the remaining 5 did not specify [14, 17, 20, 27, 29] .
Eleven studies used at least one antiplatelet drug immediately postoperatively, which was continued for varying lengths of time, ranging from 3 months to indefinitely [2, 7, 11, 13-15, 20, 22, 24, 29, 30] . Five of these also administered concurrent anticoagulant therapy consisting of either warfarin or unfractionated heparin ( Table 2) [7, 13, 15, 27, 28] . Seven studies administered neither antiplatelets nor anticoagulants postoperatively [17-19, 23, 25, 26] .
Preoperative matching and quality score
Three studies adequately matched CE and CABG groups for all preoperative demographics [7, 11, 19 ] and 14 studies compared preoperative characteristics of their study and control groups [2, 7, 11, 14, 15, [19] [20] [21] [22] [23] [24] [25] [26] [27] , demonstrating significant differences in preoperative characteristics. Five studies did not report on preoperative characteristics [16] [17] [18] [19] 29] . The overall quality scores are demonstrated in Table 3 . Ten studies were perceived to be of relative 'high'-quality scoring ≥8 [2, 7, 11, 14, 20, 21, [23] [24] [25] [26] .
Risk-of-bias analysis
Risk-of-bias analysis revealed several areas for concern, particularly regarding randomization, allocation concealment and blinding (Fig. 2) . Furthermore, no studies currently demonstrate a design to satisfactorily exclude selection, performance and detection bias. Four of the six studies reporting angiographic patency present incomplete data [15, 17, 18, 26] , only performing follow-up angiographies in symptomatic patients. Only eight studies had prespecified outcomes that were adequately reported [2, 13, 18-20, 22, 25, 26] . In addition to this, four studies did not disclose preoperative and intraoperative characteristics of the patients [16] [17] [18] 29] , whereas one had significant differences in control and intervention groups of the study [20] . These issues raise concerns around attrition, reporting and other bias, respectively. Visual inspection of funnel plots did not reveal any significant outliers (using 95% CIs) for any of our primary or secondary outcomes. Begg and Mazumdar's test and Egger's test similarly did not demonstrate any significant small study effects for any of the outcomes reported.
Pre-and intraoperative characteristics
Overall, pooled analysis revealed no significant difference in age, ejection fraction, obesity, smoking, diabetes mellitus, hypercholesterolemia, hypertension, chronic obstructive pulmonary disease, renal failure, heart failure and family history of coronary heart disease between CE and CABG groups. However, CE patients were more likely to have atheroma involving three or more vessels (OR = 2.06, 95% CI [1.82-2.33], P <0.00001) and concomitant peripheral vascular disease (OR = 1.80, 95% CI [1.34-2.42], P = 0.0001).
As expected, endarterectomy was associated with a significant increase in CPB and cross-clamp time (OR = 15.63, 95% CI [11.29-19 .96], P <0.00001 and OR = 11.94, 95% CI [0.49-23.39], P = 0.04, respectively); however, the number of grafts per patient was not significantly different between the two groups (P = 0.83).
The overall results of for both primary and secondary end-points are shown in Table 4 .
Primary end-points
Thirty-day mortality was significantly higher after endarterectomy when compared with patients undergoing CABG only (20 studies; OR = 1.69, 95% CI [1.49-1.92], P <0.00001), without significant heterogeneity (χ 2 = 11.09, I 2 <0.01%, P = 0.92; Fig. 3A ).
The incidence of both peri-and postoperative MI was also significantly higher in the endarterectomy group (OR = 2.10, 95% CI [1.82-2.43], P <0.00001 and OR = 3.34, 95% CI [1.74-6.41], P = 0.0003, respectively), although significant heterogeneity was present for the postoperative MI outcome (χ 2 = 43.56, I 2 = 79%, P <0.00001) (Fig. 3B and C) . (Table 4) .
Secondary end-points
Endarterectomy also significantly increased ITU (WMD = 0.91, 95% CI [0.36-1.45], P = 0.001) and hospital stay (WMD = 1.15, 95% CI [0.58-1.72], P <0.0001) when compared with CABG only, although significant heterogeneity was present (χ 2 = 124.91, I 2 = 97%, P <0.00001; χ 2 = 30.16, I 2 = 87%, P <0.00001, respectively). Furthermore, angiographic patency at follow-up was significantly worse in the CE group compared with the CABG-only group (OR = 0.57, 95% CI [0.36-0.88], P = 0.01), without heterogeneity (Table 4) .
Subgroup analysis
Full results of subgroup analysis are shown in Table 5 . [27] Hepatin (SC) started 6 h postoperatively and continued with warfarin or acenocoumarol (INR = 2-3) for 3-6 months and then switched to aspirin 100-125 mg daily in 71 patients in CE group. Remaining patients in CE group and 100 patients in CABG group only received aspirin 100-125 mg daily from first postoperative day Asimakopoulos et al. [7] Warfarin (INR = 2) and aspirin 75-150 mg OD for 3 months. After 3 months, warfarin stopped and aspirin continued indefinitely Christakis et al. [1] IV dipyridamole intra and postoperatively Demirtas et al. [28] Heparin (IV) started 2-3 days postoperatively continued with warfarin for a duration of 6 months in CE group Erdil et al. [15] Warfarin and ticlodipin 250 mg BD following extubation. Ticlodipin stopped at second postoperative month. Warfarin replaced with aspirin 300 mg at the end of sixth postoperative month Gale et al. [16] Huysmans et al. [17] Jonjev et al. [29] Antiplatelet and anticoagulant therapy administered under a special protocol-not stated Kamath et al. [18] LaPar et al. [11] Aspirin and clopidogrel for a minimum of 3 months in CE group Larock et al. [19] Livesay et al. [2] Aspirin and dipyridamole postoperatively. Miller et al. [20] Antiplatelets (e.g. sulfinpyrazone 200 mg QDS) for 2-3 months postoperatively Shapira et al. [21] Antiplatelets started 6 h postop Silberman et al. [22] Antiplatelets Sirivella et al. [23] Tasdemir et al. [24] Dipyridamole 75 mg TDS and acetylsalicylic acid OD postoperatively Tiruvoipati et al. [25] Walter et al. [26] -CE: coronary endarterectomy; INR: international normalized ratio; CABG: coronary artery bypass grafting; OD: once daily; BD: twice daily; QDS: four times daily; IV: intravenous; SC: subcutaneous. [11, 15, 27] .
STATE-OF-THE-ART
Larger (n ≥100) and high-quality studies. CE was associated with a significantly greater 30-day mortality (P <0.00001), perioperative (P = 0.0009) and postoperative (P = 0.03) MI when only larger studies (n ≥100) were analysed; however, heterogeneity remained for the postoperative MI outcome ( Table 5 ). The same effect was observed when only high-quality studies (quality score ≥8) were analysed; however, heterogeneity was no longer found to be present for the postoperative MI outcome.
Of interest, subgroup analysis of larger studies (n ≥100) also demonstrated significantly increased ITU and hospital stay with endarterectomy procedures (P <0.00001), while removing previous heterogeneity for both outcomes ( Table 5) .
Analysis of studies using matched groups or propensity score matching. Only three studies performed matched analysis of CABG and CABG + CE groups [7, 11, 19] . Analysis of these three studies as a separate subgroup was only possible for 30-day mortality and postoperative MI outcomes, given the limited data available. There was a tendency towards increased postoperative MI in the CE group although this did not reach statistical significance (OR = 4.99, 95% CI [0.80-31.24], P = 0.09) and moderate heterogeneity was present (I 2 = 56%, χ 2 = 4.58, P = 0.10). No significant difference in 30-day mortality was observed in subgroup analysis of matched studies (OR = 2.46, 95% CI [0.75-8.06], P = 0.14), without significant heterogeneity (I 2 <0.01%, χ 2 = 1.85, P = 0.40). Notably, however, the study by Larock et al. 
DISCUSSION
Over the past three decades, there has been a re-emergence of CE. However, the incidence of CE performed in combination with CABG varies from 3.7 to 42%, reflecting a lack of consistency for its indications [25] . Despite the higher operative risk associated with CE, good long-term results have supported its selective use in diffuse coronary artery disease where the distal vessel is unsuitable for CABG alone [2, 31] . In this study, we evaluated the safety and efficacy of CE, focusing on its short-term morbidity, mortality and long-term coronary vessel patency. Our results quantitatively demonstrated an increase in the incidence of postoperative MI and 30-day mortality following integration of CE with CABG. These results remained significant in subgroup analyses of studies published on or after the year 2000, larger studies (n ≥100) and those with quality scores ≥8.
An increase in the incidence of MI after endarterectomy is supported by a number of larger studies [31] [32] [33] [34] . However, although reports in recent years suggest comparable morbidity and mortality rates after CE combined with CABG [11] , this meta-analysis reveals that the procedure continues to significantly increase both morbidity and mortality associated with myocardial revascularization, supporting long-standing concerns over the risk associated with the procedure.
Despite improvements in surgical techniques, CE causes mechanical trauma to the coronary vessel, leading to a loss of endothelial integrity and function [35, 36] . Furthermore, the procedure itself can result in atheroemboli and even produce intimal tears within the coronary vessel [33] . As such, CE is associated with an increased tendency to de novo thrombogenesis and embolization from dislodged atheromatous material, which can result in MI and subsequent mortality. Furthermore, CE of the LAD is thought to confer higher morbidity and mortality when compared with other vessels [2, 7, 22, 33] , potentially as a result of atheroembolization into multiple septal branches. However, these results are conflicted by other studies [25, 37] and independent analysis of this subgroup was not possible because of insufficient data and combined reporting of outcomes for both left and right coronary systems. Preventative measures for reducing perioperative MI have included initial coronary reperfusion with cardioplegia solution and suction of debris through the arteriotomy [19, 21, 24, 26] ; however, the uptake of such techniques is not universal and their effectiveness is unknown. Routine use of antiplatelet agents or other anticoagulants could further reduce postoperative MI by counteracting the increased tendency to thrombogenesis within endarterectomized vessels. However, our results highlight the lack of uniformity in anticoagulant administration and, as such, the need for a more standardized management protocol.
In the early postoperative period, the results of this meta-analysis also demonstrated significantly worse morbidity in terms of ventricular arrhythmias, pulmonary complications, renal failure, inotrope use and blood transfusion requirements. Furthermore, this translates into an increased ITU and hospital stay in patients undergoing CE. This is in part likely to be a result of a greater preoperative atherosclerotic burden in CE patients affecting coronary, peripheral and renal vasculature. Furthermore, the increased complexity of the CE procedure and consequent longer aortic cross-clamp, cardioplegia and bypass time could lead to prolonged renal hypoperfusion and increased postoperative clotting dysfunction.
In the long term, this study also highlights potentially lower patency rates of grafts observed with adjunct CE when compared with CABG alone. Graft patency can be influenced by several factors, including the type of conduit, intraoperative graft flow, flow in the endarterectomized vessel, diameters of reconstructed artery and distal native artery, previous MI in the territory of endarterectomized vessel and the use of antithrombotic therapy [19, 23, 24, 33, 38] . However, denudation of the coronary endothelium by endarterectomy promotes thrombogenesis and releases a cascade of inflammatory mediators, including homocystiene, interleukin-1β and matrix metalloproteinases [39] . This process not only produces oxidative stress leading to prolonged consumption of endogenous antioxidants [40] , but also increases nitric oxide (NO) synthease inhibitor production, thus reducing NO availability [39, 40] . In this way, CE might not only result in increased vascular smooth muscle cell proliferation and gradual reocclusion of the endarterectomized vessel, but also create 
Strengths and limitations
This meta-analysis incorporated a total of 54 440 patients, which would be difficult to accumulate prospectively. However, a number of limitations should be considered. Firstly, all 20 studies included in this review were observational; only 2 of which were prospective [14, 21] . One study was a retrospective review of prospective data taken from a randomized controlled trial of offversus on-pump CPB [13] . Ten of the 20 studies were determined to be of low-quality according to a modified Newcastle-Ottawa scale, with no studies adequately reporting or performing randomization, allocation concealment or blinding. Given that all studies were small and none were randomized controlled trials, it is possible that small study effects might have biased our results despite our attempts to assess this using funnel plot analysis, Egger and Begg and Mazumdar's tests. In addition, only three studies adequately matched CABG and CABG + CE groups, leading to potential selection bias. Secondly, patients undergoing CE were significantly more likely to have atheroma involving three or more vessels (P <0.00001) and were exposed to a significantly longer CPB time (P <0.00001). Furthermore, the use of both off-and on-pump techniques combined with a mixture of arterial and venous conduits adds several unquantifiable confounders, particularly when assessing longterm patency. Thirdly, although higher postoperative mortality has previously been associated with CE of LAD over other coronary vessels, is it was not possible to separate this subgroup from the overall outcome data. Furthermore, only 12 studies reported their postoperative anticoagulation strategies, which varied from dual antiplatelet to lifelong warfarin therapy. Finally, patency rate at follow-up was mostly based on angiographic studies conducted in only symptomatic patients, potentially leading to an overestimation of long-term patency as a result of both attrition and reporting bias.
CONCLUSION
This meta-analysis suggests that adjunctive CE significantly increases 30-day mortality and peri-and postoperative MI following CABG. Furthermore, our findings demonstrated the procedure to be associated with significantly higher postoperative morbidity and lower long-term graft patency. However, it should be noted that, although these studies represent a large cohort of procedures carried out over a long time period, there remains a lack of prospective evidence, and a wide range of confounding factors might influence these results, including CE technique, location of endarterectomized vessel, the use of CPB and variations in postoperative anticoagulation. To better determine whether CE should still remain a viable adjunct to CABG, novel studies should focus on collecting prospective data with standardized inclusion criteria for CE as well as isolating outcomes for different coronary vessels, and standardizing postoperative anticoagulation regimens.
